This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Intentional self-harm by unspecified means
VWXY20_INTENTI_SELF_H_UNSPE_MEANS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
459 |
4. Check minimum number of eventsNone |
459 |
5. Include endpointsNone |
459 |
6. Filter based on genotype QC (FinnGen only) |
459 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X[6-7]|X8[0-4]
Similar endpoints
↥List of similar endpoints to
Intentional self-harm by unspecified means
based on the number of shared cases.
Similar with more cases:
- Suicide or other Intentional self-harm
- Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders
- Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls
- Any mental disorder
- External causes of morbidity and mortality
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 459 | 276 | 183 |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | 0.08 |
| Median age at first event (years) | 33.98 | 30.59 | 39.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 412
- Matched controls
- 4122
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
X84
ICD-10 Finland
Intentional self-harm by unspecified means
+∞
323.0
412
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
67.4
232.7
272
115
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
50.6
171.6
209
82
N05AH04
ATC
quetiapine; oral
16.2
134.8
274
449
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
25.1
119.5
177
120
F32.9
ICD-10 Finland
Depressive episode, unspecified
11.8
102.2
230
398
N05AH03
ATC
olanzapine; systemic
16.8
95.6
165
157
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
14.6
88.6
163
176
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
33.6
80.4
106
42
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
47.6
74.2
90
24
N05BA04
ATC
oxazepam; oral
7.5
71.1
214
517
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
16.7
68.1
114
92
X78
ICD-10 Finland
Intentional self-harm by sharp object
67.3
67.6
77
14
N06AX16
ATC
venlafaxine; oral
8.4
66.6
171
319
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
10.8
65.5
139
186
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
15.5
65.4
113
98
F29
ICD-10 Finland
Unspecified nonorganic psychosis
14.9
65.4
115
104
N06AX11
ATC
mirtazapine; oral
6.4
65.2
237
716
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
7.9
64.8
175
350
N07BB01
ATC
disulfiram; oral
19.4
63.3
99
66
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
34.4
62.2
81
29
N05AX12
ATC
aripiprazole; systemic
13.6
61.7
113
111
AA1AD
NOMESCO Finland
CT of head and brain
8.0
59.1
154
285
N05AX08
ATC
risperidone; systemic
11.1
58.6
120
147
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
21.4
55.3
83
48
N05BA01
ATC
diazepam; systemic, rectal
8.3
54.6
136
231
N03AX09
ATC
lamotrigine; oral
11.5
54.4
108
123
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
7.6
50.7
134
246
N05CF01
ATC
zopiclone; oral
5.4
48.5
185
540
N06AB04
ATC
citalopram; systemic
5.7
47.3
164
425
P15
ICPC
Chronic alcohol abuse
22.4
46.3
68
36
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
9.3
46.2
103
142
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
24.7
45.7
65
31
N03AG01
ATC
valproic acid; systemic, rectal
11.3
45.6
90
99
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.1
45.5
112
181
N06AB10
ATC
escitalopram; oral
5.0
45.3
189
598
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
36.5
44.6
57
18
N06AB06
ATC
sertraline; oral
6.6
44.6
130
268
N05AA02
ATC
levomepromazine; systemic
13.2
44.5
81
75
F60.9
ICD-10 Finland
Personality disorder, unspecified
25.8
44.3
62
28
F10.25
ICD-10 Finland
Alcohol dependence continuous use
39.4
43.8
55
16
N06AB03
ATC
fluoxetine; oral
6.8
43.7
123
241
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.6
42.7
146
365
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
13.9
42.3
75
65
F10.09
ICD-10 Finland
Alcohol intoxication UNS
17.4
40.0
64
43
N03AX16
ATC
pregabalin; oral
5.3
39.4
142
372
F10.20
ICD-10 Finland
Alcohol dependence currently independent
29.5
38.7
52
20
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
36.9
38.5
49
15
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
26.3
38.2
53
23
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
5.5
38.1
130
318
X59
ICD-10 Finland
Exposure to unspecified factor
5.0
38.1
147
413
F10.24
ICD-10 Finland
Alcohol depence active use
42.9
37.4
46
12
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
28.3
36.8
50
20
N05CD07
ATC
temazepam; oral
8.5
36.0
83
118
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
10.5
35.9
73
83
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.2
35.0
168
577
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
29.3
35.0
47
18
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
10.2
34.9
72
84
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
12.8
34.7
63
57
S06.0
ICD-10 Finland
Concussion
5.7
34.4
110
246
ZY000
NOMESCO Finland
Hospital inpatient
16.0
34.1
56
40
N05BA06
ATC
lorazepam; systemic, sublingual
11.5
33.8
65
66
N03AE01
ATC
clonazepam; systemic
10.0
33.3
69
81
N05BE01
ATC
buspirone; oral
15.8
32.7
54
39
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
7.6
32.3
80
126
Z2446
NOMESCO Finland
Social worker
6.8
32.3
87
155
Z72.8
ICD-10 Finland
Other problems related to lifestyle
34.8
31.9
41
13
R56.8
ICD-10 Finland
Other and unspecified convulsions
8.4
31.9
74
105
C07AA05
ATC
propranolol; systemic
4.1
31.1
148
495
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.2
30.9
107
259
N05AH02
ATC
clozapine; systemic
14.0
30.5
53
43
TPH04
NOMESCO Finland
Cathetrisation of vein
4.4
30.5
130
391
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
10.1
30.2
62
71
B18.2
ICD-10 Finland
Chronic viral hepatitis C
21.7
29.4
43
22
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
7.5
29.0
72
113
Z91.5
ICD-10 Finland
Personal history of self-harm
59.5
28.6
33
6
WX892
NOMESCO Finland
Monitored bed care
7.9
28.6
68
100
F61.0
ICD-10 Finland
Mixed personality disorders
15.4
28.4
47
34
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
83.7
28.2
31
*
N05AF03
ATC
chlorprothixene; systemic
13.7
28.1
49
40
N05AN01
ATC
lithium; oral
13.7
28.1
49
40
N05AD01
ATC
haloperidol; systemic
15.0
28.0
47
35
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
7.5
27.5
68
106
F99
ICD-10 Finland
Mental disorder, not otherwise specified
12.8
27.2
49
43
ZY010
NOMESCO Finland
Hospital outpatient
6.1
27.1
79
154
N06AX12
ATC
bupropion; oral
5.7
26.9
84
178
P29
ICPC
Psychological sympt/compl other
5.2
26.8
91
213
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
31.7
26.8
35
12
N05CF02
ATC
zolpidem; oral
4.3
26.5
113
334
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
11.7
26.1
49
47
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
15.3
26.0
43
31
IGY02
NOMESCO Finland
Psychiatric monitoring contact
11.0
25.8
50
51
AA400
NOMESCO Finland
Electroconvulsive therapy
22.5
25.7
37
18
P99
ICPC
Psychological disorders other
9.7
25.5
53
62
N05BA12
ATC
alprazolam; oral
5.8
25.4
77
157
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
32.5
25.4
33
11
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
11.4
25.3
48
47
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.5
25.1
69
124
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
6.6
24.7
67
118
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
37.1
24.6
31
9
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
6.2
24.6
70
132
TKC20
NOMESCO Finland
Catheterisation of bladder
8.6
24.2
54
71
P74
ICPC
Anxiety disorder/anxiety state
6.4
24.1
67
122
IGY99
NOMESCO Finland
Other psychiatric treatment contact
11.1
24.0
46
46
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.0
23.5
207
1050
S51.7
ICD-10 Finland
Multiple open wounds of forearm
57.6
23.3
27
5
NA1AD
NOMESCO Finland
Cervical spine CT examination
10.4
23.2
46
49
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
32.2
23.1
30
10
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
5.0
22.9
79
186
Z3231
NOMESCO Finland
Registered nurse
3.2
22.9
150
621
N02AX02
ATC
tramadol; systemic, rectal
3.1
22.8
171
775
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.0
22.8
79
187
F31.8
ICD-10 Finland
Other bipolar affective disorders
10.8
22.7
44
45
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
29.3
22.6
30
11
P18
ICPC
Medication abuse
21.0
22.5
33
17
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.5
22.2
122
440
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
19.8
22.1
33
18
F39
ICD-10 Finland
Unspecified mood [affective] disorder
9.2
22.1
47
57
P76
ICPC
Depressive disorder
4.9
22.0
78
189
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.2
21.8
72
161
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
6.4
21.7
59
104
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
10.3
21.7
43
46
TPH07
NOMESCO Finland
Cathetrisation of artery
6.1
21.7
62
117
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
24.8
21.6
30
13
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
15.8
21.6
35
24
N03AX12
ATC
gabapentin; oral
4.3
21.3
87
243
N06AX21
ATC
duloxetine; oral
4.5
21.3
81
211
IGV01
NOMESCO Finland
Psychiatric network contact
19.1
21.2
32
18
R02
ICPC
Shortness of breath/dyspnoea
4.8
21.1
75
182
R53
ICD-10 Finland
Malaise and fatigue
3.4
21.0
120
443
F20.9
ICD-10 Finland
Schizophrenia, unspecified
10.5
20.9
41
43
N06AX26
ATC
vortioxetine; oral
5.6
20.8
64
132
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
20.7
167
784
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
11.2
20.6
39
38
Z2445
NOMESCO Finland
Psychologist
6.3
20.6
57
103
R51.80
ICD-10 Finland
Headache
3.4
20.5
114
412
N06AX05
ATC
trazodone; oral
13.0
20.5
36
30
S18
ICPC
Laceration/cut
2.8
20.4
181
898
K04.0
ICD-10 Finland
Pulpitis
4.0
20.3
88
259
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
24.9
20.2
28
12
X58
ICD-10 Finland
Exposure to other specified factors
3.6
20.1
104
355
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
60.7
20.1
23
*
P19
ICPC
Drug abuse
11.2
20.1
38
37
XF400
NOMESCO Finland
ECG with 12 standard connections
4.2
20.1
82
228
ZXD05
NOMESCO Finland
Urgent procedure
2.9
20.0
160
744
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
8.6
19.6
43
55
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
9.2
19.4
41
49
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
48.5
19.4
23
5
S51.8
ICD-10 Finland
Open wound of other parts of forearm
24.0
19.3
27
12
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
10.8
18.8
36
36
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
40.5
18.7
23
6
Z72.2
ICD-10 Finland
Drug use
17.2
18.6
29
18
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
6.4
18.5
50
87
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
18.7
18.5
28
16
N06AB05
ATC
paroxetine; oral
6.0
18.4
52
96
P16
ICPC
Acute alcohol abuse
12.3
18.3
33
29
M79.6
ICD-10 Finland
Pain in limb
2.7
18.3
163
799
T74.1
ICD-10 Finland
Physical abuse
8.6
18.3
40
51
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
6.1
18.3
51
93
P01
ICPC
Feeling anxious/nervous/tense
3.0
18.2
124
514
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
34.7
18.2
23
7
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.6
18.1
55
111
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
17.6
18.1
28
17
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
28.2
18.0
24
9
N02BE01
ATC
paracetamol; systemic, rectal
3.1
18.0
350
2659
IEV99
NOMESCO Finland
Other psychiatric network intervention
24.1
18.0
25
11
N05AE04
ATC
ziprasidone; systemic
24.1
18.0
25
11
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
7.7
17.9
42
60
N05AB03
ATC
perphenazine; systemic, rectal
7.9
17.8
41
57
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
3.3
17.7
100
362
P03
ICPC
Feeling depressed
3.3
17.7
101
369
JN3AD
NOMESCO Finland
Abdominal CT examination
6.4
17.6
47
81
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
19.7
17.6
26
14
N06AX03
ATC
mianserin; oral
8.6
17.5
38
48
F60.2
ICD-10 Finland
Dissocial personality disorder
33.1
17.2
22
7
T18.9
ICD-10 Finland
Foreign body in alimentary tract, part unspecified
52.4
17.1
20
*
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
26.9
17.1
23
9
WX882
NOMESCO Finland
High dependency care
11.9
17.0
31
28
EBA00
NOMESCO Finland
Extraction of tooth
2.5
17.0
189
1038
N04AA02
ATC
biperiden; systemic
13.5
16.9
29
23
L17
ICPC
Foot/toe symptom/complaint
2.9
16.9
127
554
A01
ICPC
Pain general/multiple sites
5.2
16.9
54
116
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
8.1
16.8
38
51
WX290
NOMESCO Finland
Other blockade of nerve
2.4
16.7
264
1737
T51.0
ICD-10 Finland
Toxic effect: Ethanol
21.1
16.6
24
12
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
9.0
16.6
35
42
Z72.1
ICD-10 Finland
Alcohol use
15.1
16.6
27
19
W19
ICD-10 Finland
Unspecified fall
4.3
16.5
64
168
P06
ICPC
Sleep disturbance
3.8
16.5
75
228
SPAT1240
SPAT
Therapeutic discussion
3.1
16.4
105
412
R42
ICD-10 Finland
Dizziness and giddiness
3.3
16.4
91
324
R07.4
ICD-10 Finland
Chest pain, unspecified
3.1
16.3
104
406
Z3226
NOMESCO Finland
Physiotherapist
3.2
16.2
100
380
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
7.9
16.1
37
51
N06AA12
ATC
doxepin; systemic
8.9
16.1
34
41
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
11.9
16.0
29
26
SPAT1254
SPAT
Administration of medicine
3.2
15.9
96
362
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
13.7
15.9
27
21
SAA01
NOMESCO Finland
Simple examination of mouth
2.8
15.9
340
2598
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
8.7
15.9
34
42
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
27.5
15.7
21
8
SPAT1260
SPAT
Consultation of another employee
3.1
15.7
101
396
N05BA02
ATC
chlordiazepoxide; systemic
13.0
15.6
27
22
C07AB07
ATC
bisoprolol; oral
2.7
15.6
134
629
X57
ICD-10 Finland
Unspecified privation
9.8
15.5
31
34
R11
ICD-10 Finland
Nausea and vomiting
4.3
15.4
60
158
F41.1
ICD-10 Finland
Generalized anxiety disorder
4.3
15.4
60
158
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
14.7
15.2
25
18
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.3
15.2
255
1692
S22.3
ICD-10 Finland
Fracture of rib
6.2
15.1
41
72
WX110
NOMESCO Finland
Local anesthesy
2.6
15.1
331
2512
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
15.8
15.1
24
16
F50.9
ICD-10 Finland
Eating disorder, unspecified
9.7
15.0
30
33
F60.0
ICD-10 Finland
Paranoid personality disorder
58.9
14.9
17
*
L12
ICPC
Hand/finger symptom/complaint
3.1
14.9
91
345
F93.89
ICD-10 Finland
Other childhood emotional disorders
9.0
14.8
31
37
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
5.5
14.8
44
87
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
14.7
90
342
A46
ICD-10 Finland
Erysipelas
3.9
14.7
64
187
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
8.4
14.6
32
41
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
6.3
14.6
39
67
S00.8
ICD-10 Finland
Superficial injury of other parts of head
13.2
14.6
25
20
S01.0
ICD-10 Finland
Open wound of scalp
4.9
14.5
48
107
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
17.8
14.5
22
13
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.1
14.4
58
157
F34.1
ICD-10 Finland
Dysthymia
6.6
14.3
37
61
W22
ICD-10 Finland
Striking against or struck by other object(s)
4.3
14.3
55
143
ZYC01
NOMESCO Finland
Remote contact by phone
5.5
14.3
43
86
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.7
14.2
49
114
SPAT1301
SPAT
No procedures
2.4
14.1
150
786
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
8.3
14.1
31
40
J01DB01
ATC
cefalexin; oral
2.8
14.1
354
2825
Z71.8
ICD-10 Finland
Other specified counselling
2.5
14.1
139
701
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
16.5
14.1
22
14
ZXY49
NOMESCO Finland
Other health care provider
13.3
14.1
24
19
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
7.8
14.0
32
44
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
9.6
13.9
28
31
A02BC02
ATC
pantoprazole; systemic
2.2
13.9
234
1523
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
20.9
13.9
20
10
F05.9
ICD-10 Finland
Delirium, unspecified
20.9
13.9
20
10
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
24.8
13.9
19
8
F51.0
ICD-10 Finland
Nonorganic insomnia
3.0
13.9
88
338
SPAT1227
SPAT
Substance abuse rehabilitation
14.2
13.9
23
17
K59.09
ICD-10 Finland
Constipation, unspecified
6.0
13.7
38
69
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.5
13.7
49
119
F41.8
ICD-10 Finland
Other specified anxiety disorders
5.7
13.6
39
74
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
5.7
13.6
39
74
Y87.0
ICD-10 Finland
Sequelae of intentional self-harm
144.5
13.5
14
*
S69.9
ICD-10 Finland
Unspecified injury of wrist and hand
9.0
13.5
28
33
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
26.8
13.5
18
7
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
13.5
66
212
F40.1
ICD-10 Finland
Social phobias
5.6
13.4
39
75
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
13.3
122
587
D11
ICPC
Diarrhoea
3.0
13.3
83
317
N02AJ06
ATC
codeine and paracetamol; systemic
2.3
13.2
171
979
-1
NOMESCO Finland
NA
2.2
13.1
207
1297
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
17.4
13.1
20
12
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
29.4
13.1
17
6
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
23.4
13.0
18
8
A06AD11
ATC
lactulose; oral
3.6
13.0
60
184
SPAT1265
SPAT
Breathalyser
11.0
12.9
24
23
F43.1
ICD-10 Finland
Post-traumatic stress disorder
5.2
12.9
40
83
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.5
12.9
33
54
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.2
12.8
237
1589
Z3229
NOMESCO Finland
Other healthcare associate professional
4.2
12.8
49
127
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
16.1
12.7
20
13
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
6.7
12.7
32
51
W17
ICD-10 Finland
Other fall from one level to another
5.3
12.7
39
80
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
72.1
12.7
14
*
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.7
12.7
100
442
XF600
NOMESCO Finland
Bloodpressure measurement
5.3
12.5
38
77
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
7.5
12.5
29
41
L03
ICPC
Low back symptom/complaint
2.4
12.5
122
606
T18.2
ICD-10 Finland
Foreign body in stomach
133.9
12.5
13
*
M54.5
ICD-10 Finland
Low back pain
2.3
12.5
149
817
F31
ICD-10 Finland
Bipolar affective disorder
12.2
12.5
22
19
R41.0
ICD-10 Finland
Disorientation, unspecified
14.9
12.4
20
14
A28
ICPC
Limited function/disability NOS
4.4
12.4
45
111
Z2221
NOMESCO Finland
Medical doctor
2.4
12.3
132
685
N03AX11
ATC
topiramate; oral
7.3
12.3
29
42
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
8.2
12.3
27
35
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
38.8
12.3
15
*
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
8.6
12.2
26
32
R55
ICD-10 Finland
Syncope and collapse
4.0
12.2
50
138
F92.0
ICD-10 Finland
Depressive conduct disorder
18.8
12.1
18
10
N05AF05
ATC
zuclopenthixol; systemic
27.6
12.1
16
6
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
22.1
12.1
17
8
M54.4
ICD-10 Finland
Lumbago with sciatica
3.0
12.1
76
291
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
12.1
72
266
R52.9
ICD-10 Finland
Pain, unspecified
3.8
12.1
52
150
ZXA00
NOMESCO Finland
Right side
2.7
12.0
94
413
L16
ICPC
Ankle symptom/complaint
3.2
12.0
66
230
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.2
11.9
66
231
WX872
NOMESCO Finland
Intensive care
6.7
11.9
30
48
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
15.2
11.9
19
13
ZXY60
NOMESCO Finland
2-person team, nurses
10.1
11.9
23
24
WX730
NOMESCO Finland
Conventional respirator
10.1
11.9
23
24
T90
ICPC
Diabetes non-insulin dependent
3.2
11.9
65
225
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.6
11.8
55
169
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
13.1
11.7
20
16
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
13.1
11.7
20
16
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
19.6
11.7
17
9
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
66.9
11.7
13
*
QCB00
NOMESCO Finland
Suture of skin of upper limb
10.5
11.6
22
22
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.0
11.6
73
279
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
14.2
11.6
19
14
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.0
11.5
37
80
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
3.0
11.5
72
274
WX402
NOMESCO Finland
General anaesthesia
2.8
11.4
82
340
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
6.0
11.4
31
55
D12
ICPC
Constipation
7.6
11.4
26
36
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.8
11.4
49
141
R4120
NOMESCO Finland
Occupational therapy
4.4
11.4
41
100
D01
ICPC
Abdominal pain/cramps general
2.9
11.4
76
302
L28
ICPC
Limited function/disability (L)
3.5
11.4
54
169
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.1
11.3
44
116
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
17.6
11.3
17
10
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
25.8
11.2
15
6
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
20.7
11.2
16
8
SPAT1149
SPAT
Suture or treatment of traumatic wound
3.3
11.1
57
190
R33
ICD-10 Finland
Retention of urine
5.0
11.0
35
75
WX704
NOMESCO Finland
Intubation
3.9
11.0
45
124
F32
ICD-10 Finland
Depressive episode
4.1
11.0
43
114
S10
ICPC
Boil/carbuncle
4.4
11.0
40
99
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
44.6
11.0
13
*
F13.09
ICD-10 Finland
Intoxication caused by sedative and hypnotic UNS
44.6
11.0
13
*
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
44.6
11.0
13
*
R4110
NOMESCO Finland
Physiotherapy
2.4
10.9
108
534
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
16.0
10.9
17
11
WX002
NOMESCO Finland
Sedation and analgesia
2.8
10.9
73
290
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
9.2
10.9
22
25
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
10.9
90
406
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
18.4
10.8
16
9
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
18.4
10.8
16
9
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
10.8
85
373
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
28.9
10.8
14
5
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
28.9
10.8
14
5
P77
ICPC
Suicide/suicide attempt
28.9
10.8
14
5
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
22.2
10.8
15
7
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
13.4
10.7
18
14
RS221
NOMESCO Finland
NA
13.4
10.7
18
14
F32.8
ICD-10 Finland
Other depressive episodes
8.3
10.7
23
29
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
4.7
10.7
36
82
J45.9
ICD-10 Finland
Asthma, unspecified
2.7
10.7
78
326
N17
ICPC
Vertigo/dizziness
3.3
10.7
55
183
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
11.7
10.7
19
17
N01
ICPC
Headache
2.4
10.6
100
482
P72
ICPC
Schizophrenia
7.7
10.6
24
33
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
14.7
10.6
17
12
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.4
10.5
105
520
EBA30
NOMESCO Finland
Excision of root of tooth
4.8
10.5
34
75
NC2AA
NOMESCO Finland
Forearm X-ray examination
12.5
10.4
18
15
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
16.6
10.4
16
10
S61.7
ICD-10 Finland
Multiple open wounds of wrist and hand
16.6
10.4
16
10
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
10.4
153
907
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
3.2
10.4
57
197
ZXA05
NOMESCO Finland
Left side
2.5
10.3
87
396
F50.1
ICD-10 Finland
Atypical anorexia nervosa
13.6
10.2
17
13
IER01
NOMESCO Finland
Psychoeducation, group
13.6
10.2
17
13
N07BA03
ATC
varenicline; oral
4.1
10.2
40
106
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
10.2
121
652
K08.3
ICD-10 Finland
Retained dental root
3.9
10.2
42
117
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
8.8
10.2
21
25
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.4
10.2
50
161
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
6.4
10.2
26
43
C03CA01
ATC
furosemide; systemic
2.9
10.1
66
258
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.0
10.1
59
215
S29
ICPC
Skin symptom/complaint other
2.6
10.0
78
339
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
17.2
9.9
15
9
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
26.8
9.9
13
5
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
26.8
9.9
13
5
D09
ICPC
Nausea
3.5
9.8
47
148
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.9
9.8
61
232
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.3
9.8
49
160
L15
ICPC
Knee symptom/complaint
2.4
9.8
93
450
F33.8
ICD-10 Finland
Other recurrent depressive disorders
13.8
9.7
16
12
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.6
9.7
75
323
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
56.3
9.7
11
*
SGC00
NOMESCO Finland
Local medication of root channels of tooth
2.8
9.7
66
264
S19
ICPC
Skin injury other
5.2
9.6
29
59
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.3
9.6
35
87
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
15.5
9.6
15
10
S02
ICPC
Pruritus
4.8
9.5
31
69
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.8
9.5
31
69
A02BC01
ATC
omeprazole; systemic
2.3
9.5
97
484
QDB00
NOMESCO Finland
Suture of skin of lower limb
102.3
9.5
10
*
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
30.8
9.4
12
*
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
30.8
9.4
12
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.5
9.4
33
79
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
+∞
9.4
9
*
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
22.3
9.4
13
6
P98
ICPC
Psychosis NOS/other
11.0
9.4
17
16
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
11.0
9.4
17
16
UJD02
NOMESCO Finland
Gastroscopy
6.0
9.4
25
44
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
9.8
9.4
18
19
SGA01
NOMESCO Finland
Tooth opening as first aid
2.3
9.4
92
450
A29
ICPC
General symptom/complaint other
3.1
9.3
52
182
G72.8
ICD-10 Finland
Other specified myopathies
14.1
9.2
15
11
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
14.1
9.2
15
11
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
8.6
9.2
19
23
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
7.3
9.1
21
30
IGP01
NOMESCO Finland
Psychiatric family contact
11.8
9.1
16
14
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
10.4
9.1
17
17
N06AX22
ATC
agomelatine; oral
5.5
9.1
26
50
SPAT1307
SPAT
Psychosocial counselling and guidance
2.6
9.1
69
295
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.7
9.1
66
275
T68
ICD-10 Finland
Hypothermia
37.6
9.1
11
*
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.6
9.1
41
124
ZZA00
NOMESCO Finland
Split skin graft
7.7
9.0
20
27
J01FF01
ATC
clindamycin; systemic
2.1
9.0
113
618
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.8
9.0
62
249
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
19.1
9.0
13
7
L84
ICPC
Back syndrome without radiat pain
5.2
9.0
27
55
N05AA01
ATC
chlorpromazine; systemic, rectal
12.9
8.9
15
12
ZYD01
NOMESCO Finland
Emergency clinic
12.9
8.9
15
12
K10.3
ICD-10 Finland
Alveolitis of jaws
3.9
8.9
36
99
IEY01
NOMESCO Finland
Psychoeducation, individual
8.9
8.9
18
21
A04
ICPC
Weakness/tiredness general
2.5
8.8
73
327
ND1AA
NOMESCO Finland
Wrist X-ray examination
3.9
8.8
35
95
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
14.4
8.7
14
10
P80
ICPC
Personality disorder
14.4
8.7
14
10
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
8.7
37
106
S51
ICD-10 Finland
Open wound of forearm
51.1
8.7
10
*
X80
ICD-10 Finland
Intentional self-harm by jumping from a high place
51.1
8.7
10
*
R44.3
ICD-10 Finland
Hallucinations, unspecified
51.1
8.7
10
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.1
8.7
121
691
D64.9
ICD-10 Finland
Anaemia, unspecified
4.0
8.7
34
91
L09
ICPC
Arm symptom/complaint
4.8
8.7
28
62
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
11.9
8.6
15
13
L11
ICPC
Wrist symptom/complaint
2.9
8.6
54
206
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
16.7
8.6
13
8
Z72.0
ICD-10 Finland
Tobacco use
6.2
8.6
22
37
R05
ICPC
Cough
2.2
8.5
99
522
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
28.2
8.5
11
*
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
20.5
8.5
12
6
F10.07
ICD-10 Finland
Pathological alcohol intoxication
91.8
8.4
9
*
S97
ICPC
Chronic ulcer skin
5.5
8.4
24
46
SPAT1272
SPAT
Drug screening
13.1
8.4
14
11
WX725
NOMESCO Finland
Noninvasive ventilation
4.6
8.4
28
64
SPAT1252
SPAT
Overall medication plan or its review
4.6
8.4
28
64
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.0
8.4
26
55
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
8.4
41
132
X76
ICD-10 Finland
Intentional self-harm by smoke, fire and flames
+∞
8.4
8
*
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
2.8
8.3
55
215
F50.2
ICD-10 Finland
Bulimia nervosa
9.7
8.3
16
17
S71.1
ICD-10 Finland
Open wound of thigh
9.7
8.3
16
17
H53.2
ICD-10 Finland
Diplopia
6.7
8.3
20
31
Z00.0
ICD-10 Finland
General medical examination
2.2
8.3
92
477
P27
ICPC
Fear of mental disorder
5.9
8.3
22
39
K20
ICD-10 Finland
Oesophagitis
14.9
8.2
13
9
P86
ICPC
Anorexia nervosa/bulimia
14.9
8.2
13
9
SPAT1263
SPAT
Sampling
1.9
8.2
190
1301
R60.0
ICD-10 Finland
Localized oedema
3.3
8.2
40
129
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
12.0
8.1
14
12
RT150
NOMESCO Finland
NA
34.1
8.1
10
*
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
34.1
8.1
10
*
R44.0
ICD-10 Finland
Auditory hallucinations
34.1
8.1
10
*
K02.1
ICD-10 Finland
Caries of dentine
1.9
8.1
275
2142
R1250
NOMESCO Finland
Evaluation of functional capability
9.2
8.1
16
18
Y96.9
ICD-10 Finland
Unspecified type of accident
9.2
8.1
16
18
I95.1
ICD-10 Finland
Orthostatic hypotension
10.3
8.1
15
15
V03AA01
ATC
NA
10.3
8.1
15
15
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
10.3
8.1
15
15
R06.0
ICD-10 Finland
Dyspnoea
2.2
8.1
84
421
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
8.0
75
356
W10
ICD-10 Finland
Fall on and from stairs and steps
4.7
8.0
26
58
M01AE02
ATC
naproxen; oral, rectal
1.8
8.0
244
1827
P17
ICPC
Tobacco abuse
8.0
7.9
17
22
L05
ICPC
Flank/axilla symptom/complaint
4.0
7.9
31
83
F33
ICD-10 Finland
Recurrent depressive disorder
5.9
7.9
21
37
D06
ICPC
Abdominal pain localized other
3.1
7.9
44
153
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.2
7.9
40
133
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.8
7.9
32
89
N05AF01
ATC
flupentixol; systemic
11.1
7.8
14
13
S50.1
ICD-10 Finland
Contusion of other and unspecified parts of forearm
11.1
7.8
14
13
S51.0
ICD-10 Finland
Open wound of elbow
11.1
7.8
14
13
XX1XW
NOMESCO Finland
Extensive written report from radiologist
9.7
7.8
15
16
Y94.0
ICD-10 Finland
Accident at home
9.7
7.8
15
16
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
9.7
7.8
15
16
A11
ICPC
Chest pain NOS
4.0
7.8
30
79
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.3
7.8
38
122
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
7.8
55
223
N06AA09
ATC
amitriptyline; systemic
3.4
7.8
37
117
A13
ICPC
Concern/fear medical treatment
15.4
7.8
12
8
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
45.8
7.7
9
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.1
7.7
29
75
ZXD35
NOMESCO Finland
Usual procedure
5.1
7.7
23
47
S21
ICPC
Skin texture symptom/complaint
2.6
7.7
58
246
KMAK
NOMESCO Finland
NA
1.8
7.7
232
1722
Y94.8
ICD-10 Finland
Other leisure activity accident
5.3
7.7
22
43
UJF32
NOMESCO Finland
Coloscopy
2.3
7.6
77
379
ZYY01
NOMESCO Finland
Contact between professionals
18.8
7.6
11
6
S00.7
ICD-10 Finland
Multiple superficial injuries of head
18.8
7.6
11
6
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
18.8
7.6
11
6
TUPKY
NOMESCO Finland
NA
12.2
7.6
13
11
Y34
ICD-10 Finland
Unspecified event, undetermined intent
12.2
7.6
13
11
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
7.6
81
408
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
5.9
7.6
20
35
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
25.5
7.6
10
*
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
25.5
7.6
10
*
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
25.5
7.6
10
*
RS220
NOMESCO Finland
NA
10.3
7.6
14
14
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
10.3
7.6
14
14
ZXE00
NOMESCO Finland
One hour or less
1.9
7.6
157
1028
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.7
7.6
51
203
L08
ICPC
Shoulder symptom/complaint
2.4
7.6
68
318
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
7.3
7.6
17
24
SPAT1234
SPAT
Support of social functional capacity
4.2
7.5
27
67
P01AB01
ATC
metronidazole; oral, rectal
1.9
7.5
146
937
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.7
7.5
51
204
S50.0
ICD-10 Finland
Contusion of elbow
4.7
7.5
24
53
XF404
NOMESCO Finland
Ambulatory ECG
3.6
7.5
32
93
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
7.5
101
566
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
7.5
188
1312
D72
ICPC
Viral hepatitis
81.5
7.4
8
*
F19.51
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances paranoid
81.5
7.4
8
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.1
7.4
39
133
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
13.7
7.4
12
9
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
13.7
7.4
12
9
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
7.4
126
769
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
7.4
88
468
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.1
7.4
22
45
K92.0
ICD-10 Finland
Haematemesis
7.0
7.4
17
25
G44.2
ICD-10 Finland
Tension-type headache
2.3
7.4
69
329
SPAT1167
SPAT
Insertion of urinary catheter
11.1
7.3
13
12
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
11.1
7.3
13
12
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
7.3
43
158
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
+∞
7.3
7
*
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
+∞
7.3
7
*
G43.9
ICD-10 Finland
Migraine, unspecified
2.9
7.3
43
159
S14
ICPC
Burn/scald
4.4
7.2
25
60
K59.0
ICD-10 Finland
Constipation
3.9
7.2
28
75
N06AB08
ATC
fluvoxamine; oral
6.8
7.2
17
26
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
6.8
7.2
17
26
IAA02
NOMESCO Finland
Consultation concerning further psychiatric treatment
20.4
7.2
10
5
N05AE05
ATC
lurasidone; oral
20.4
7.2
10
5
RS211
NOMESCO Finland
NA
20.4
7.2
10
5
E86
ICD-10 Finland
Volume depletion
8.1
7.2
15
19
N06AA04
ATC
clomipramine; systemic
8.1
7.2
15
19
W26
ICD-10 Finland
Contact with other sharp object(s)
5.8
7.2
19
34
SPAT1310
SPAT
Counselling related to known health issue
1.8
7.1
147
959
Z27
ICPC
Fear of a social problem
12.3
7.1
12
10
Z03
ICPC
Housing/neighbourhood problem
12.3
7.1
12
10
D10
ICPC
Vomiting
2.6
7.1
51
209
SPAT1153
SPAT
Removal of sutures
2.0
7.1
103
590
F60.8
ICD-10 Finland
Other specific personality disorders
10.3
7.1
13
13
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
10.3
7.1
13
13
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.6
7.0
49
200
S80.0
ICD-10 Finland
Contusion of knee
3.0
7.0
40
143
L03.9
ICD-10 Finland
Cellulitis, unspecified
6.5
7.0
17
27
F50.0
ICD-10 Finland
Anorexia nervosa
6.5
7.0
17
27
F41.00
ICD-10 Finland
Moderate panic disorder
5.6
7.0
19
35
U04
ICPC
Incontinence urine
6.0
7.0
18
31
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
7.0
168
1149
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.6
7.0
30
88
N02AA05
ATC
oxycodone; systemic
2.9
7.0
41
151
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.0
7.0
39
137
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
7.7
7.0
15
20
K92.1
ICD-10 Finland
Melaena
5.0
6.9
21
44
SPAT1274
SPAT
Brief intervention in person with addiction symptoms
14.1
6.9
11
8
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
14.1
6.9
11
8
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.9
6.9
27
73
N05AX13
ATC
paliperidone; systemic
8.5
6.9
14
17
Y07
ICD-10 Finland
Other maltreatment
8.5
6.9
14
17
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
6.9
43
163
L01
ICPC
Neck symptom/complaint
2.3
6.9
66
319
UKC02
NOMESCO Finland
Cystoscopy
2.6
6.8
48
197
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.7
6.8
28
79
T82
ICPC
Obesity
3.8
6.8
27
74
S89.9
ICD-10 Finland
Unspecified injury of lower leg
4.3
6.8
24
59
A97
ICPC
No disease
2.1
6.8
78
407
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.1
6.8
25
64
IDY24
NOMESCO Finland
Systematic individual treatment, dialectical behaviour therapy (DBT), pre-treatment
40.7
6.8
8
*
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
40.7
6.8
8
*
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
17.0
6.8
10
6
T11.1
ICD-10 Finland
Open wound of upper limb, level unspecified
17.0
6.8
10
6
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
17.0
6.8
10
6
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.6
6.8
29
85
R25.2
ICD-10 Finland
Cramp and spasm
7.4
6.8
15
21
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
5.1
6.8
20
41
M25.5
ICD-10 Finland
Pain in joint
1.9
6.7
112
677
N06AA06
ATC
trimipramine; systemic
5.3
6.7
19
37
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
22.9
6.7
9
*
N05AB01
ATC
dixyrazine; systemic
22.9
6.7
9
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.7
6.7
18
33
RF220
NOMESCO Finland
NA
8.0
6.7
14
18
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
8.0
6.7
14
18
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.3
6.7
64
307
N30.0
ICD-10 Finland
Acute cystitis
2.3
6.6
62
295
S91.3
ICD-10 Finland
Open wound of other parts of foot
4.9
6.6
20
42
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.9
6.6
20
42
Y28
ICD-10 Finland
Contact with sharp object, undetermined intent
12.5
6.6
11
9
R40.2
ICD-10 Finland
Coma, unspecified
10.3
6.6
12
12
WX400
NOMESCO Finland
Inhalation anesthesy
3.6
6.6
28
82
-50
ICPC
Medication/prescr/renewal
4.2
6.5
23
57
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.9
6.5
25
67
A10BA02
ATC
metformin; oral
2.2
6.5
66
328
J01MA12
ATC
levofloxacin; systemic
2.4
6.5
58
268
R50.9
ICD-10 Finland
Fever, unspecified
2.2
6.5
65
319
X70
ICD-10 Finland
Intentional self-harm by hanging, strangulation and suffocation
70.9
6.4
7
*
RS311
NOMESCO Finland
NA
70.9
6.4
7
*
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
14.6
6.4
10
7
S60.8
ICD-10 Finland
Other superficial injuries of wrist and hand
14.6
6.4
10
7
T58
ICD-10 Finland
Toxic effect of carbon monoxide
14.6
6.4
10
7
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
6.4
48
204
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.2
6.4
65
322
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.0
6.4
34
118
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.7
6.4
20
44
E87.6
ICD-10 Finland
Hypokalaemia
5.7
6.4
17
31
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
11.3
6.3
11
10
F60.5
ICD-10 Finland
Anankastic personality disorder
9.5
6.3
12
13
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
6.3
71
368
M79.1
ICD-10 Finland
Myalgia
2.2
6.3
62
301
F43.02
ICD-10 Finland
Acute stress reaction severe
18.3
6.3
9
5
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
7.2
6.3
14
20
Y98
ICD-10 Finland
Lifestyle-related condition
+∞
6.3
6
*
JDA08
NOMESCO Finland
Endoscopic removal of foreign body from stomach or pylorus
+∞
6.3
6
*
F15.9
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, unspecified mental and behavioural disorder
+∞
6.3
6
*
A08
ICPC
Swelling
5.2
6.3
18
36
ZYD04
NOMESCO Finland
Emergency outreach service, another specialty
27.1
6.2
8
*
X09
ICD-10 Finland
Exposure to unspecified smoke, fire and flames
27.1
6.2
8
*
SPAT1127
SPAT
Enema
27.1
6.2
8
*
WX720
NOMESCO Finland
Own respiration
4.6
6.2
20
45
WVA20
NOMESCO Finland
Medicine administration
6.4
6.2
15
24
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.4
6.2
28
86
NDJ64
NOMESCO Finland
Internal fixation of fracture of wrist or hand wire, rod, cerclage or pin
5.9
6.2
16
28
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
5.9
6.2
16
28
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.9
6.2
24
65
K04
ICPC
Palpitations/awareness of heart
3.9
6.2
24
65
N89
ICPC
Migraine
3.2
6.1
30
98
D02
ICPC
Abdominal pain epigastric
3.1
6.1
32
110
S31.1
ICD-10 Finland
Open wound of abdominal wall
12.8
6.1
10
8
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
12.8
6.1
10
8
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
12.8
6.1
10
8
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
12.8
6.1
10
8
R96
ICPC
Asthma
2.8
6.1
37
140
N80
ICPC
Head injury other
8.8
6.1
12
14
R25.1
ICD-10 Finland
Tremor, unspecified
6.9
6.1
14
21
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
10.2
6.1
11
11
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
4.7
6.1
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
153
182
12.11
126.61
5.0
2.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
88
37
29.19
126.42
2.6
1.3
promille
1.5
1.6
0.10
68
29
(1001926) Buprenorphine [Presence] in Urine by Screen method
182
337
8.29
103.23
4.6
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
193
397
7.66
98.66
4.7
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
165
291
8.29
97.32
7.1
2.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
195
433
7.09
91.63
4.7
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
194
429
7.10
91.53
4.7
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
237
636
6.64
91.26
3.5
1.8
%
1.7
1.4
5.95
222
588
(3027008) Opiates [Presence] in Urine
194
431
7.06
91.04
4.7
2.0
—
—
—
0
0
(4198724)
66
37
20.67
83.45
3.3
2.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
180
429
6.26
76.97
4.3
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
305
1178
5.74
73.59
9.0
5.6
mmol/l
1.2
1.2
1.21
290
1080
(3002032) Base excess in Venous blood by calculation
126
228
7.24
70.86
4.7
3.4
mmol/l
1.5
1.9
0.63
104
178
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
311
1301
5.31
65.70
10.0
6.2
mmol/l
1.2
1.2
1.66
272
1126
(3003396) Base excess in Arterial blood by calculation
121
242
6.43
61.03
9.6
10.1
mmol/l
-0.2
0.9
1.64
95
184
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
224
761
4.80
60.78
4.4
2.1
u/l
325.0
271.5
0.21
218
725
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
287
1179
4.83
60.62
6.2
3.0
u/l
32.6
30.6
0.51
278
1118
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
249
933
4.65
59.05
5.3
2.4
u/l
58.9
55.1
0.25
233
866
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
327
1531
4.95
56.87
9.1
5.3
umol/l
8.9
10.4
3.45
311
1445
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
53
41
14.48
56.33
27.7
18.3
nmol/l
1670.6
1423.3
0.56
53
41
(3009508) Creatinine [Moles/volume] in Urine
235
892
4.35
53.62
4.7
3.1
mmol/l
7.4
8.8
2.68
208
785
(3032080) INR in Blood by Coagulation assay
240
939
4.26
52.19
9.8
5.7
inr
1.1
1.1
0.07
76
314
(3000991) Gas panel - Venous blood
103
204
6.22
51.99
10.0
8.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
140
377
4.90
49.72
1.9
1.6
nmol/l
1091.2
1134.9
0.23
110
300
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
76
115
7.72
49.60
9.2
15.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
189
656
4.20
47.84
5.9
3.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
342
1803
4.52
46.97
10.3
4.4
mmol/l
6.4
6.4
0.01
328
1610
(3024561) Albumin [Mass/volume] in Serum or Plasma
255
1100
3.97
46.97
6.4
4.4
g/l
35.8
37.4
4.23
241
1039
(3021960) Folate [Moles/volume] in Serum or Plasma
171
562
4.26
46.50
1.8
1.4
nmol/l
17.8
19.6
1.01
157
485
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
76
129
6.86
44.45
4.7
3.4
mmol/l
24.1
24.1
0.01
67
117
(3015377) Calcium [Moles/volume] in Serum or Plasma
218
889
3.77
42.76
2.8
2.7
mmol/l
2.3
2.4
0.55
202
799
(3012095) Magnesium [Moles/volume] in Serum or Plasma
134
389
4.45
42.65
4.5
3.2
mmol/l
0.8
0.8
2.04
128
372
(3018418) pH of Serum or Plasma
202
787
3.80
42.38
3.9
3.4
ph
7.4
7.4
0.13
44
128
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
136
413
4.26
40.57
2.5
1.9
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
50
59
9.39
39.84
7.2
5.9
umol/l
402.2
391.1
0.17
43
53
(42870588) Differential panel, method unspecified - Blood
244
1108
3.57
39.82
8.4
5.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
390
2413
5.10
39.45
11.7
6.5
u/l
77.7
73.9
1.23
377
2268
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
228
1026
3.43
37.12
2.5
1.6
pmol/l
94.1
95.6
0.18
160
552
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
94
230
4.88
36.75
2.9
2.5
g/l
0.2
0.2
0.65
86
212
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
105
282
4.53
36.54
2.4
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
71
138
5.90
35.99
6.6
7.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
114
335
4.20
35.13
5.0
5.9
mmol/l
1.0
1.0
0.26
108
314
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
32
23
14.88
35.12
1.8
1.7
iu/ml
1266155.6
1224630.0
—
8
5
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
103
285
4.37
34.35
2.5
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
35
31
12.14
33.95
2.1
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
62
113
6.19
33.52
1.9
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
121
402
3.73
31.00
2.7
2.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
309
1790
3.22
30.84
11.7
6.0
e9/l
0.2
0.2
0.31
273
1605
(3001604) Monocytes [#/volume] in Blood
301
1726
3.16
30.42
10.2
5.6
e9/l
0.6
0.5
2.19
263
1521
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
206
960
3.08
30.17
5.8
2.7
ng/l
22.7
23.9
0.07
127
446
(3009343) pH of Capillary blood
71
161
5.03
30.14
4.6
3.1
ph
7.4
7.4
—
7
17
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
103
312
3.97
30.11
3.5
2.5
u/l
30.5
30.4
0.01
80
257
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
70
157
5.08
30.10
4.5
3.1
mmol/l
0.6
1.0
0.34
54
120
(3006315) Basophils [#/volume] in Blood
300
1733
3.11
29.62
10.2
5.6
e9/l
0.0
0.0
0.04
263
1526
(3024928) Oxygen saturation in Venous blood
39
49
8.61
29.43
2.0
2.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
63
132
5.37
29.25
2.3
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
328
2004
3.23
29.09
19.9
8.1
e9/l
4.2
4.0
1.07
283
1746
(3022096) Basophils/100 leukocytes in Blood
281
1581
3.00
28.81
9.6
5.7
%
0.6
0.7
3.21
258
1482
(3033658) Prothrombin time (PT) actual/Normal
172
747
3.08
28.19
8.5
3.5
%
90.9
95.5
1.59
167
735
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
391
2692
4.05
27.74
8.1
2.7
u/l
55.5
36.6
3.87
381
2588
(3006504) Eosinophils/100 leukocytes in Blood
285
1641
2.94
27.55
9.8
5.6
%
2.4
2.8
1.75
264
1537
(3019069) Monocytes/100 leukocytes in Blood
286
1652
2.94
27.44
10.4
5.8
%
8.2
8.2
0.06
265
1564
(3019198) Lymphocytes [#/volume] in Blood
304
1818
2.99
27.26
10.2
5.6
e9/l
2.1
2.0
0.77
269
1640
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
171
753
3.03
27.18
2.3
2.0
mg/l
2.8
2.8
0.11
155
645
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
86
254
3.94
25.82
5.6
2.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
28
27
10.98
25.58
4.7
2.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
291
1737
2.85
25.52
10.2
5.5
%
29.4
30.0
0.40
268
1648
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
125
480
3.20
24.96
4.8
2.9
ng/l
117.8
447.4
0.68
76
276
(3027945) Reticulocytes/100 erythrocytes in Blood
78
221
4.05
24.77
1.6
3.8
%
1.9
1.7
0.63
73
197
(3026008) Bacteria identified in Urine by Culture
182
865
2.83
24.71
3.7
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
53
114
5.13
23.77
5.0
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
61
148
4.60
23.70
1.4
3.4
e9/l
66.8
70.2
0.21
40
110
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
65
167
4.37
23.48
2.0
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
281
1713
2.65
22.54
10.1
5.4
%
55.8
55.8
0.02
259
1624
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
387
2794
3.46
22.24
5.8
3.9
pmol/l
14.3
14.4
0.35
364
2572
(40758558) Short blood count panel - Blood
172
831
2.71
22.18
11.3
6.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
21
16
13.71
22.10
1.8
2.1
umol/l
15.2
14.1
0.17
21
16
(3022948) Iron [Moles/volume] in Serum or Plasma
105
390
3.19
21.93
2.0
2.2
umol/l
13.9
15.0
0.44
98
357
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
37
63
6.30
21.22
3.0
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
98
357
3.22
21.08
4.7
2.3
umol/l
8.0
7.1
0.18
83
288
(3017143) Hepatitis C virus Ab [Presence] in Serum
151
698
2.73
21.08
2.1
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
104
394
3.12
20.93
1.8
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
230
1309
2.52
20.79
2.8
2.2
nmol/l
64.2
70.8
3.12
215
1215
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
47
105
4.87
20.11
5.5
3.3
mmol/l
23.4
24.5
1.04
47
100
(3023103) Potassium [Moles/volume] in Serum or Plasma
437
3492
6.25
20.04
32.3
9.9
mmol/l
3.9
3.9
0.37
428
3362
(3004789) Transferrin [Mass/volume] in Serum or Plasma
96
358
3.13
19.77
2.0
2.2
g/l
2.4
2.4
0.01
87
327
(3019150) Specific gravity of Urine by Refractometry
163
805
2.59
19.71
3.8
3.1
kg/l
1.0
1.0
0.35
15
98
(3019550) Sodium [Moles/volume] in Serum or Plasma
435
3478
5.79
19.59
33.0
9.9
mmol/l
139.3
139.6
1.60
427
3363
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
90
325
3.20
19.56
2.1
2.3
%
21.5
25.7
1.59
72
283
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
189
1011
2.48
19.18
4.5
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
125
549
2.75
19.05
3.6
2.3
mosm/kgh2o
503.2
574.5
2.19
113
471
(3013707) Erythrocyte sedimentation rate by Westergren method
349
2476
2.71
18.81
4.4
3.4
mm/h
10.8
8.5
2.78
324
2304
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
120
524
2.75
18.43
1.8
1.6
pmol/l
441.3
28936589.6
0.80
105
470
(3018095) Leukocytes [#/volume] in Urine
195
1085
2.39
17.84
5.2
3.2
e6/l
121.1
114.2
0.03
132
703
(3022217) INR in Platelet poor plasma by Coagulation assay
69
224
3.45
17.73
13.4
16.0
inr
1.1
1.2
—
6
40
(3044889) 12 lead EKG panel
306
2088
2.40
17.15
4.3
2.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
19
19
10.39
16.80
1.4
2.6
%
10.7
12.5
0.78
19
19
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
416
3314
3.72
16.78
7.3
4.4
mu/l
1.6
2.1
0.80
396
3113
(3013512) EKG study
137
667
2.50
16.66
5.3
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
153
786
2.42
16.52
4.5
2.6
e6/l
0.2
0.3
0.53
115
569
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
102
433
2.74
16.38
3.4
2.5
e6/l
7.6
3.8
1.19
52
212
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
46
119
4.18
16.34
1.5
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
65
217
3.32
15.93
2.2
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
163
874
2.34
15.86
4.5
2.7
e6/l
80.4
144.7
0.31
124
652
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
57
176
3.56
15.77
2.9
2.6
mmol/l
1.2
1.2
0.08
49
151
(36304419) Bacteria [Presence] in Urine
151
793
2.35
15.34
4.5
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
332
2416
2.35
15.01
6.2
3.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
101
457
2.55
14.11
3.3
2.4
e6/l
1.2
1.0
0.15
51
235
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
91
4.33
14.01
1.5
2.5
g/l
1.6
1.2
0.90
28
80
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
141
745
2.29
13.92
2.2
1.9
mg/l
0.7
0.9
0.96
102
524
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
438
3713
4.93
13.86
30.0
9.8
mg/l
19.3
20.7
0.53
380
2808
(40767503) Oxygen content in Capillary blood by calculation
25
44
5.95
13.82
2.7
2.4
%
17.1
16.2
0.54
14
19
(3010421) pH of Blood
31
67
4.89
13.74
4.2
2.0
ph
7.4
7.4
2.77
26
52
(3012501) Base excess in Blood by calculation
27
52
5.45
13.60
4.1
2.1
mmol/l
2.0
2.7
0.76
13
32
(3021589) Normoblasts [#/volume] in Blood
241
1583
2.10
13.56
16.3
7.5
e9/l
0.0
0.0
0.27
189
1284
(1616796) Gas panel - Central venous blood
25
45
5.82
13.51
3.2
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
57
196
3.18
13.25
1.6
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
368
2872
2.42
13.02
5.5
4.2
mmol/mol
38.4
37.9
0.41
347
2728
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
241
1605
2.06
12.83
6.0
3.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
167
984
2.10
12.28
3.2
2.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
16
6
27.54
12.12
3.2
2.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
66
260
2.80
12.04
1.7
4.4
u/l
208.9
243.6
1.99
61
252
(3052851) Hemolysis interference index of Serum or Plasma
30
71
4.45
11.92
3.7
2.4
—
—
—
0
0
(3020891) Body temperature
36
98
3.90
11.91
10.1
4.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
76
324
2.61
11.88
1.9
1.7
nmol/l
377.2
407.0
0.62
69
297
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
99
478
2.37
11.86
2.3
3.0
ng/l
473.0
721.4
0.84
67
374
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
396
3242
2.61
11.80
5.7
3.3
mmol/l
5.9
5.6
2.53
374
3008
(3000850) Epithelial cells [#/volume] in Urine
112
586
2.21
11.02
3.7
2.3
e6/l
7.9
8.5
0.13
99
510
(3021387) Prolactin [Units/volume] in Serum or Plasma
64
260
2.70
10.98
1.9
1.5
mu/l
593.4
295.3
3.03
54
233
(3021901) Oxygen saturation in Capillary blood
21
39
5.59
10.97
2.0
2.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
448
2.32
10.73
1.9
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
214
1433
1.92
10.56
2.5
2.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
52
196
2.86
10.27
1.6
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
247
1748
1.89
10.16
4.1
3.0
estimate
0.0
0.0
0.00
56
344
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
179
1146
1.92
9.98
2.1
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
130
747
2.03
9.90
3.2
2.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
35
107
3.46
9.79
1.3
1.3
titre
130.0
58.0
—
5
10
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
438
3866
3.91
9.75
18.5
7.9
u/l
33.6
27.4
2.99
431
3740
(3012516) Albumin [Mass/volume] in Urine
114
628
2.08
9.71
3.0
3.5
mg/l
1200.4
84.0
0.74
71
428
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
24
56
4.47
9.70
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
132
771
2.00
9.56
3.4
3.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
41
5.05
9.39
3.8
4.7
u/ml
0.4
0.4
—
10
23
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
134
791
1.98
9.39
1.8
1.6
mmol/l
1.8
1.4
4.51
112
707
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
63
275
2.50
9.31
3.5
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
25
64
4.07
8.99
1.3
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
15
8.19
8.90
1.3
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
389
3287
2.20
8.64
23.7
8.3
ml/min/173m2
102.0
96.7
5.30
327
2590
(3019225) pH of Specimen
56
240
2.52
8.59
5.1
3.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
248
1821
1.79
8.48
3.2
2.8
ug/l
91.4
80.7
0.40
233
1717
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
41
151
2.88
8.44
2.2
2.1
ug/l
8.2
7.5
0.07
35
138
(3020682) Albumin/Creatinine [Ratio] in Urine
113
652
1.97
8.35
3.7
4.3
mg/mmol
3.0
13.8
4.17
69
442
(3000494) Fungus identified in Specimen by Culture
75
373
2.21
8.22
1.9
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
241
1766
1.77
8.20
4.2
3.0
estimate
0.0
0.0
0.00
54
335
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
17
7.22
8.03
1.3
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
80
3.52
7.92
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
24
5.99
7.90
1.3
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
76
386
2.16
7.89
3.9
2.4
u/l
5986.2
2882.4
0.24
17
162
(3021601) Nitrite [Presence] in Urine by Test strip
237
1744
1.74
7.81
5.8
4.1
estimate
0.0
0.0
0.00
56
353
(3017509) Phencyclidine [Presence] in Urine
12
8
15.35
7.75
2.3
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
624
0.29
7.63
1.3
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
439
3968
3.44
7.58
27.9
8.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
383
3266
2.04
7.55
37.6
11.9
%
13.8
13.3
8.01
378
3205
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
54
4.03
7.51
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
54
4.03
7.51
1.7
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
78
408
2.10
7.49
2.0
2.4
mmol/l
2.4
2.4
0.87
67
353
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
9
13.65
7.42
4.1
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
394
3406
2.11
7.30
4.3
3.3
mmol/l
4.6
4.7
0.63
378
3235
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
172
1180
1.73
7.11
3.0
2.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
67
3.56
6.93
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
34
126
2.83
6.93
2.0
2.6
s
19.3
20.8
1.35
26
108
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
11
8
14.05
6.92
1.5
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
136
2.70
6.54
2.4
2.3
ng/l
121.9
124.7
0.02
30
118
(3023410) Appearance of Cerebral spinal fluid
15
33
4.67
6.50
1.5
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
29
4.95
6.49
1.4
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
158
1086
1.69
6.34
2.8
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
392
3432
1.97
6.26
4.6
3.5
mmol/l
2.7
2.8
1.35
374
3233
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
387
3388
1.91
5.98
4.2
3.3
mmol/l
1.4
1.4
2.48
368
3205
(3005719) IgG [Mass/volume] in Serum or Plasma
53
260
2.17
5.98
1.8
2.2
g/l
10.5
10.6
0.01
45
235
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
23
76
3.13
5.73
1.4
1.3
e6/l
614.8
138.6
0.47
16
60
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
23
76
3.13
5.73
1.4
1.2
e6/l
11.3
7.3
0.17
15
56
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
374
3259
1.80
5.61
3.8
3.0
mmol/l
1.5
1.2
3.76
350
3079
(40768797) Stomach Pathology biopsy report
67
369
1.96
5.55
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
47
3.72
5.53
1.6
1.7
—
—
—
0
0
(4010399)
43
200
2.27
5.52
1.3
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
40
3.84
5.13
1.2
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
65
3.17
5.13
1.5
3.3
e9/l
5.4
3.9
1.20
20
65
(40761536) Microorganisms panel - Urine sediment
58
313
1.98
5.09
5.1
3.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
19
5.36
5.06
3.2
2.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
66
3.12
5.00
1.6
3.3
%
60.8
56.1
0.90
20
66
(3002179) Metamyelocytes/100 leukocytes in Blood
46
233
2.08
4.80
4.8
4.5
%
0.1
0.4
1.95
12
53
(3000475) Leukocytes [#/volume] in Synovial fluid
16
47
3.49
4.79
1.3
1.7
e6/l
2996.2
23227.6
0.98
11
33
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
79
2.87
4.78
2.0
1.3
ug/g
283.3
301.5
0.16
14
42
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
33
4.03
4.74
1.2
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
52
277
1.99
4.73
2.9
3.5
pmol/l
4.6
4.7
0.41
46
244
(3029937) Albumin [Presence] in Urine by Test strip
132
925
1.60
4.69
4.5
3.2
estimate
0.0
0.0
0.80
54
343
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
69
2.99
4.66
1.9
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
69
2.99
4.66
1.8
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
12
29
4.22
4.65
2.8
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
250
2.03
4.65
5.7
4.7
%
0.6
0.8
0.36
15
73
(3021440) Promyelocytes/100 leukocytes in Blood
46
236
2.05
4.64
5.9
4.9
%
0.0
0.2
1.95
14
65
(3025159) Blasts/100 leukocytes in Blood
45
229
2.07
4.64
6.1
4.8
%
0.0
0.2
0.73
14
56
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
5
14.18
4.59
1.4
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
11
8.32
4.58
1.0
1.6
nmol/l
151.3
169.6
—
9
11
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
54
296
1.93
4.53
8.6
5.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
108
2.49
4.30
2.4
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
27
4.15
4.18
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
483
0.41
4.15
1.3
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
23
4.42
4.11
3.3
2.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
55
314
1.85
4.09
4.3
3.0
%
32.0
31.2
0.19
48
221
(44790047)
13
37
3.59
4.08
2.1
1.6
—
—
—
0
0
(44790048)
13
37
3.59
4.08
2.1
1.6
—
—
—
0
0
(44790049)
13
37
3.59
4.08
2.1
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
37
3.59
4.08
1.1
1.1
—
—
—
0
0
(44806118)
13
37
3.59
4.08
2.1
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
731
0.52
4.02
1.7
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
113
2.38
3.93
2.6
2.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
24
4.24
3.90
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
24
4.24
3.90
1.1
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
101
693
1.59
3.85
2.5
2.4
umol/l
3760.7
3898.9
0.01
86
620
(3023419) Bacteria identified in Sputum by Culture
10
25
4.07
3.71
2.6
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
12
6.76
3.68
2.3
6.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
51
3.01
3.60
1.2
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
174
1361
1.45
3.52
4.4
3.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
448
4275
3.00
3.52
46.1
14.3
e9/l
265.6
258.2
1.61
441
4167
(3037121) Protein [Mass/volume] in Urine
24
106
2.33
3.52
3.6
3.6
g/l
0.2
0.3
—
6
56
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
36
3.40
3.50
1.3
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
23
100
2.37
3.49
1.5
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
106
1435
0.66
3.45
2.6
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
86
583
1.58
3.44
2.3
2.5
ug/g
94.8
98.5
0.07
66
465
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
95
2.38
3.39
3.1
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
448
4281
2.94
3.39
46.0
14.3
e12/l
4.5
4.6
6.84
441
4176
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
10
7.09
3.37
4.7
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
10
7.09
3.37
4.7
2.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
10
7.09
3.37
1.4
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
58
359
1.70
3.31
1.3
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
448
4285
2.90
3.30
46.4
14.3
e9/l
7.4
6.7
9.13
441
4174
(3049717) Cytology report of Urine Cyto stain
18
73
2.53
3.16
1.8
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
137
1044
1.45
3.12
3.9
2.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
74
2.49
3.08
2.9
1.5
—
—
—
0
0
(4146454)
8
16
5.07
3.06
1.3
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
85
590
1.54
3.06
2.1
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
100
719
1.50
3.05
2.3
2.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
5
10.09
2.98
2.4
1.4
umol/l
26.0
22.8
—
5
5
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
5
10.09
2.98
2.0
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
35
3.20
2.95
1.4
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
73
494
1.57
2.94
1.4
1.4
titre
412.3
451.7
0.08
13
96
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
10
30
3.39
2.92
1.4
1.2
umol/l
7.0
6.4
—
10
30
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
70
2.48
2.91
1.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
121
913
1.44
2.88
1.7
1.4
g/l
2.3
2.2
0.19
69
592
(3028433) Virus identified in Specimen by Culture
7
13
5.45
2.88
1.1
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
9
6.74
2.87
2.3
8.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
84
590
1.52
2.86
1.4
1.2
iu/ml
18.7
22.7
0.28
31
183
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
31
3.28
2.79
2.0
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
50
312
1.68
2.78
2.0
2.2
nmol/l
12.6
13.6
0.32
41
292
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
6
8.41
2.75
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
116
879
1.43
2.69
6.1
4.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
275
0.39
2.67
1.5
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
16
67
2.44
2.66
1.1
1.1
iu/ml
11.0
86.0
—
6
22
(3022145) Colonoscopy Study observation
50
317
1.65
2.63
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
107
2.11
2.61
2.0
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
132
1028
1.40
2.61
1.6
1.3
u/ml
1.0
1.7
0.75
30
284
(4034850)
23
114
2.07
2.61
10.8
8.9
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
7
15
4.72
2.60
1.0
1.1
umol/l
33.1
18.1
—
7
15
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
41
247
1.72
2.60
1.4
1.4
miu/ml
165.6
258.2
—
10
126
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
20
4.05
2.58
2.0
2.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
44
2.77
2.56
1.4
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
350
0.47
2.56
1.2
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
11
5.51
2.55
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
11
5.51
2.55
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
26
3.51
2.49
1.0
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
63
2.43
2.49
1.2
1.7
g/l
4.0
3.9
—
8
51
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
63
2.43
2.49
1.2
1.7
g/l
7.7
7.3
—
9
53
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
63
2.43
2.49
1.2
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
27
3.38
2.40
1.3
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
199
1.77
2.39
2.4
2.6
ml/min/173m2
85.6
80.5
0.38
12
70
(40768443) Skin Pathology biopsy report
23
119
1.98
2.35
1.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
396
3707
1.50
2.32
33.8
10.3
%
39.2
41.1
3.75
265
3092
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
59
2.42
2.31
1.5
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
59
2.42
2.31
1.2
1.7
g/l
3.7
3.1
—
9
51
(3000093) Morphology [Interpretation] in Blood Narrative
8
23
3.52
2.28
1.1
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
36
2.82
2.21
1.1
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
42
268
1.62
2.18
2.5
2.1
e9/l
3.9
4.1
0.13
32
232
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
19
3.72
2.16
1.7
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
15
68
2.25
2.13
1.5
2.4
nmol/l
0.7
0.9
—
10
61
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
37
2.74
2.11
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
10
5.04
2.07
1.2
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
10
5.04
2.07
1.2
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
10
5.04
2.07
1.2
1.1
—
—
—
0
0
(4306422)
15
70
2.18
2.00
1.5
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
249
0.47
1.88
2.0
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
34
2.68
1.87
1.3
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
34
215
1.63
1.85
3.7
3.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
283
0.51
1.79
1.2
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
32
202
1.63
1.76
1.6
1.8
mg/l
4.2
4.1
0.03
25
133
(3003327) Ova and parasites identified in Stool by Light microscopy
24
140
1.75
1.75
1.5
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
46
0.00
1.71
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
42
2.41
1.68
1.3
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
23
135
1.74
1.65
2.5
2.8
e6/l
0.2
0.1
0.45
23
126
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
248
0.51
1.62
1.2
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
232
1.55
1.60
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
40
275
1.50
1.55
1.1
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
27
2.62
1.52
4.6
4.1
—
—
—
0
0
(4027681)
7
27
2.62
1.52
2.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
79
1.93
1.51
1.3
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.45
1.1
2.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
110
1.76
1.45
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
110
1.76
1.45
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
191
1.55
1.38
1.2
1.6
u/l
7.3
8.4
0.43
20
160
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
36
250
1.48
1.35
2.1
2.2
—
19.4
—
0
17
(40765089) Chromosome analysis panel - Blood by G-banded
0
38
0.00
1.35
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
68
1.94
1.34
2.5
2.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
113
1.71
1.34
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
41
559
0.71
1.31
1.4
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
1.0
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
35
2.31
1.27
2.1
3.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
28
188
1.52
1.24
3.6
2.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
225
0.57
1.22
1.3
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
19
2.65
1.22
1.6
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
38
2.12
1.19
2.6
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
176
1.51
1.13
2.4
4.1
ug/l
3.2
7.8
1.21
21
131
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
51
1.98
1.12
2.4
1.7
—
—
—
0
0
(4268621)
10
51
1.98
1.12
3.2
2.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
73
1.80
1.12
1.5
1.3
u/ml
3.8
4.9
—
6
34
(3021788) Differential panel - Synovial fluid
7
31
2.28
1.10
1.7
2.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
31
2.28
1.10
1.0
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
31
2.28
1.10
1.6
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
122
0.49
1.07
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
122
0.49
1.07
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
22
2.29
1.03
1.0
1.4
—
—
—
0
0
(4024509)
5
22
2.29
1.03
1.4
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
2.9
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
115
1.59
1.01
1.3
2.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
107
1.61
1.01
1.3
1.2
u/ml
299.4
220.3
0.44
11
62
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
69
1.76
0.97
1.2
1.2
—
1.2
—
0
8
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
52
1.75
0.93
2.0
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
28
2.16
0.92
4.0
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
120
1.52
0.86
3.9
2.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
18
120
1.52
0.86
1.7
1.7
pmol/l
156.3
222.1
1.26
18
115
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
18
120
1.52
0.86
1.4
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
44
1.83
0.86
1.5
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
112
1.54
0.86
1.2
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
72
1.68
0.86
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
65
1.71
0.83
3.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
130
1.48
0.82
1.5
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
139
1.46
0.80
2.3
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
33
1.83
0.79
1.5
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
1496.9
—
0
25
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
69
580
1.22
0.78
1.3
1.2
u/ml
53.5
8.1
—
9
247
(40760888) Immunoglobulin light chains.free panel - Serum
5
25
2.01
0.73
2.2
3.0
—
—
—
0
0
(44813793)
5
25
2.01
0.73
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
39
1.81
0.72
1.4
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
28
364
0.75
0.72
1.4
1.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
26
1.93
0.71
1.4
1.2
—
110.2
—
0
5
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
77
1.57
0.69
1.5
1.3
u/ml
2.8
6.5
—
5
31
(3003694) ABO and Rh group [Type] in Blood
143
1296
1.15
0.69
1.6
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
59
1.54
0.68
4.1
3.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
27
1.86
0.68
1.6
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.1
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.1
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
43
1.64
0.67
1.1
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.1
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
215
1.32
0.67
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
44
1.60
0.65
1.1
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
44
1.60
0.65
1.1
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
346
3334
1.15
0.64
4.3
3.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
29
1.73
0.64
1.8
3.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(3036603) Volume of Urine
0
20
0.00
0.60
0.0
2.0
—
2264.8
—
0
5
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
21
0.00
0.60
0.0
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
21
0.00
0.60
0.0
6.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
22
0.00
0.59
0.0
3.6
—
71.3
—
0
22
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
53
1.52
0.58
2.3
2.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
220
1.29
0.58
1.2
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
31
247
1.27
0.58
1.2
1.5
iu/l
13.0
18.6
0.72
24
206
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
35
1.72
0.58
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
373
0.79
0.57
2.3
2.3
ug/l
1.2
0.7
0.37
22
196
(3034274) Bile acid [Moles/volume] in Serum --fasting
18
134
1.36
0.54
2.3
2.2
umol/l
5.6
4.7
0.31
13
102
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
92
1.43
0.51
1.1
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
106
962
1.13
0.50
1.9
1.8
—
—
—
0
0
(4035726)
16
212
0.75
0.50
1.6
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
85
1.42
0.47
1.8
1.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
105
1.34
0.41
1.6
1.8
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
21.5
—
0
15
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
15
0.00
0.41
0.0
2.0
—
133.5
—
0
15
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
34
1.48
0.40
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
215
0.78
0.40
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.4
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
142
1.28
0.39
1.4
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
44
1.37
0.34
1.8
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
274
0.83
0.33
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
274
0.83
0.33
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
274
0.83
0.33
1.3
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
86
0.69
0.33
1.5
1.1
—
9.3
—
0
7
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
273
0.83
0.32
1.3
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
26
304
0.85
0.31
1.3
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
10
131
0.76
0.31
1.5
1.8
iu/ml
0.1
0.1
—
5
21
(1002224) Polysomnography panel
15
183
0.81
0.28
1.2
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
213
0.84
0.25
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
74
795
0.92
0.25
1.7
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
137
0.80
0.24
1.3
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
212
0.84
0.24
1.3
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
168
0.83
0.23
1.6
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
40
1.25
0.22
1.6
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
2.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
11
0.00
0.21
0.0
3.9
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
202.9
—
0
10
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
218
0.87
0.20
1.4
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
52
1.16
0.19
1.0
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
38
351
1.09
0.16
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
125
1207
1.05
0.15
1.7
1.7
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
17
150
1.14
0.14
1.1
1.7
—
9.1
—
0
6
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
39
364
1.08
0.13
1.3
1.3
iu/ml
26.7
161.6
6.93
15
145
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
53
502
1.06
0.13
2.0
1.9
—
—
—
0
0
(3000492) Spirometry study
41
386
1.07
0.12
1.8
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
12
105
1.15
0.11
1.3
1.1
u/ml
0.8
4.2
—
6
28
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
54
1.11
0.09
3.5
3.4
u/ml
3.1
4.4
—
6
46
(3039443) Prostate specific Ag panel - Serum or Plasma
5
60
0.83
0.08
1.0
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
62
0.80
0.08
1.0
1.3
—
—
—
0
0
(4094501)
7
68
1.03
0.08
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
131
0.91
0.05
1.7
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
120
1.09
0.05
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
310
0.97
0.03
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
49
501
0.98
0.03
2.6
3.3
%
17.1
21.9
1.87
22
176
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
133
1.05
0.01
1.4
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
137
0.95
0.01
1.4
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
22
224
0.98
0.00
1.3
1.1
—
134.0
—
0
5
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
169
1.01
0.00
1.6
2.2
u/ml
25.7
41.3
0.50
17
160
(40768804) Tissue Pathology biopsy report
127
1273
1.00
0.00
2.1
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
60
1.00
0.00
1.2
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
68
0.88
0.00
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
75
0.93
0.00
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
87
0.92
0.00
1.1
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.4
—
51.9
—
0
7
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
76
0.92
0.00
1.0
1.3
—
42.7
—
0
7
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.6
—
9.2
—
0
5
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
69
0.87
0.00
1.8
2.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
89
1.01
0.00
1.2
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_INTENTI_SELF_H_UNSPE_MEANS – Intentional self-harm by unspecified means
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).